AST Donation Derby IDCOP #2 funds raised #3 in participation (10%) #TxID #AST #IDCOP
Merry Christmas 🌲⭐
Recommended change in MenB-4C (Bexsero) dosing for new immunogenity data. 2-dose schedule now 0 and 6 months for age 16-23 and new 3-dose schedule (0, 1–2, and 6 months) for age 10+ high risk www.cdc.gov/mmwr/volumes...